相关实验视频
Updated: Jun 19, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
在慢性自发性疹中对奥马利祖马布升剂模式和预测因素的表征:一项前性的多中心观察性研究
Guillaume Pierrard1, Claire Bernier2,3, Aurélie Du-Thanh2,4
1CHU Lille, University Lille, Service de Dermatologie, Lille, France.
Allergy
|July 26, 2024
概括
在慢性自发性疹症 (CSU) 中,增加奥马利祖马布 (OMA) 剂量是常见的,其中20%的患者需要在3个月内调整剂量. 在低IgE水平的严重病例中,剂量增加的可能性更高.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自2014年推出以来,对慢性自发性疹 (CSU) 时的奥马利祖马布 (OMA) 剂量增加存在有限的数据.
- 缺乏实际指导方针和了解需要更高剂量的OMA的患者概况.
- 需要描述OMA升剂模式,并确定改善CSU管理的预测因素.
研究的目的:
- 在CSU患者中描述OMA剂量增加模式.
- 为了确定预测需要OMA剂量增加的因素.
- 通过OMA疗法优化,增强CSU的管理.
主要方法:
- 未来的,多中心的,现实世界的观察性研究.
- 包括开始OMA治疗的CSU患者.
- 在0个月,3个月,6个月和9个月收集数据,重点关注剂量增加频率,患者个人资料,疗效和安全性.
主要成果:
- 在153名患者中,20%的患者在3个月内增加了剂量;27%的患者在9个月内增加了剂量.
- 增加注射频率是增加剂量的主要方法 (66%).
- 增加剂量的患者在基线时有更严重的CSU,较低的淋巴细胞计数和较低的IgE水平.
结论:
- 在CSU中,Omalizumab的剂量增加很常见,在3个月内发生在五分之一的患者中.
- 严重的疾病和低IgE水平是OMA剂量增加的关键指标.
- 增加奥马利祖马布的剂量并没有增加副作用的频率.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
264
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
264
Allergic Drug Reactions
828
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
828
Antiasthma Drugs: Leukotriene Modifiers
269
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
269
Hypersensitivities
570
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
570
Allergic Reactions
27.3K
Overview
27.3K
Drugs Used in Lower Respiratory Disorders: Overview
389
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
389

